|
VETTER
 Finding the right contract manufacturer
Contract manufacturing became popular in many
industries during the 1990s as a way to counter
rising costs. The pharmaceutical industry has been
slow to adopt this practice because of its
absolute need for secrecy. However, with fewer
blockbuster drugs in the pipeline, companies are
on the lookout for an enduring solution to meet
market challenges. To maintain or expand market
share, pharmaceutical companies must devise new
strategies to remain competitive.
 Product Lifecycle Management
(PLM):
Maximizing profit
and leveraging innovation
The cost of developing a new drug is continuously
rising. Other factors, such as stricter
regulations and stronger global competition, are
also creating major challenges. If a
pharmaceutical company intends to increase its
market share and ROI, it must consider how to
maintain a drug's profitability — even after its
patents have expired. The key to successful PLM is
to create and evolve a proactive strategy
throughout its entire life — from launch to
long-term growth and acceptance in the market.
 Five keys to reducing time-to-market
With development times measured in years,
increasing costs represent a major challenge for
pharmaceutical and biotechnology companies. As a
result, reducing time-to-market is an essential
component in any business strategy. One solution
is to partner with a contract manufacturer.
To submit your white paper, please contact
Dr Kevin Robinson
|
